InspireMD, Inc. (NSPR)
NASDAQ: NSPR · IEX Real-Time Price · USD
2.360
-0.030 (-1.26%)
Jul 19, 2024, 12:00 AM EDT - Market open
InspireMD Employees
As of December 31, 2023, InspireMD had 66 total employees, including 65 full-time and 1 part-time employees. The number of employees increased by 10 or 17.86% compared to the previous year.
Employees
66
Change (1Y)
10
Growth (1Y)
17.86%
Revenue / Employee
$98,136
Profits / Employee
-$343,818
Market Cap
58.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rockwell Medical | 237 |
Enzo Biochem | 190 |
HOOKIPA Pharma | 179 |
Vor Biopharma | 168 |
Allakos | 131 |
Mural Oncology | 117 |
ProPhase Labs | 113 |
VolitionRx | 110 |
NSPR News
- 7 weeks ago - InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024 - GlobeNewsWire
- 2 months ago - InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th - GlobeNewsWire
- 3 months ago - InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 months ago - InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024 - GlobeNewsWire
- 4 months ago - InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th - GlobeNewsWire
- 5 months ago - InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System - GlobeNewsWire